Utilization of HER2 Genetic Testing in a Multi-Institutional Observational Study
Evaluation of real-world implementation of HER2 testing showed that uptake was high (>90%) and trastuzumab treatment was targeted to patients with positive HER2 status.
New Studies Highlight JAK Inhibitors’ Power as AD Treatment
Reducing Polycythemia Vera–Associated Thrombotic Risk Through Iron Regulation
Financial, Housing, Food Insecurity Raises Risk of Hospital, ED Visits
ANTHEM-UC: Icotrokinra (JNJ-2113) Shows Promise for Ulcerative Colitis